Key result
Eight elevated circulating lipids, mainly linolenic acid triacylglycerols, are linked to IgA nephropathy progression.
Why the study?
The relation of dyslipidemia patterns with obesity and disease progression in IgA nephropathy patients was unknown, and predictive markers guiding treatments were lacking.
Observational (n=196)
Specific circulating lipid profiles, particularly triacylglycerols containing linolenic acid, are associated with BMI and independently predict disease progression in IgA nephropathy.
Answers are grounded in this paper and cite their sources.
May refine progression risk stratification in IgA nephropathy; leaves open whether lipid modulation alters outcomes.
IgA nephropathy (IgAN) is a leading cause of chronic kidney disease (CKD), which are commonly accompanied by dyslipidemia. Obesity is also associated with dyslipidemia and risk of CKD, but the relation of the dyslipidemia patterns with obesity and disease progression in IgAN patients remains unknown. Traditional Chinese medicine (TCM) and the combined treatment with corticosteroids and TCM have been shown to be of benefit for IgAN patients, but predictive markers for guiding these treatments are lacking. Here, we quantified 545 lipid species in the plasma from 196 participants, including 140 IgAN patients and 56 healthy volunteers, and revealed an altered plasma lipidome in IgAN patients as compared to healthy participants. Association analysis showed that a sub-group of glycerides, particularly triacylglycerols (TGs) containing docosahexaenoic acid, were positively associated with high body mass index (BMI) in under- or normal weight IgAN patients, while several free fatty acids and sphingomyelins were positively associated with high BMI in overweight or obese IgAN patients. Further, our study suggested that elevated levels of eight lipids, mainly TG species containing linolenic acid, were independent risk factors for IgAN progression and also reported the prospective association of circulating lipids with treatment outcomes in IgAN. Taken together, our findings may not only help to achieve precision medicine but also provide a knowledge base for dietary intervention in the treatment of IgAN.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2021) conducted an observational in IgA nephropathy (n=196). Circulating lipids vs. Healthy volunteers was evaluated on IgAN progression. Elevated levels of eight circulating lipids, mainly triacylglycerols containing linolenic acid, were identified as independent risk factors for disease progression in IgA nephropathy.
Synapse has enriched 10 related papers. Consider them for comparative context: